121 related articles for article (PubMed ID: 15093604)
1. The effect of wet granulation on the erosion behaviour of an HPMC-lactose tablet, used as a rate-controlling component in a pulsatile drug delivery capsule formulation.
McConville JT; Ross AC; Chambers AR; Smith G; Florence AJ; Stevens HN
Eur J Pharm Biopharm; 2004 May; 57(3):541-9. PubMed ID: 15093604
[TBL] [Abstract][Full Text] [Related]
2. Chronopharmaceutical drug delivery from a pulsatile capsule device based on programmable erosion.
Ross AC; MacRae RJ; Walther M; Stevens HN
J Pharm Pharmacol; 2000 Aug; 52(8):903-9. PubMed ID: 11007060
[TBL] [Abstract][Full Text] [Related]
3. Preparation and tabletting of dipyridamole alginate-Eudragit microspheres.
Gürsoy A; Kalkan F; Okar I
J Microencapsul; 1998; 15(5):621-8. PubMed ID: 9743917
[TBL] [Abstract][Full Text] [Related]
4. Preparation and evaluation of a sustained-release formulation of nifedipine HPMC tablets.
Yan G; Li H; Zhang R; Ding D
Drug Dev Ind Pharm; 2000 Jun; 26(6):681-6. PubMed ID: 10826117
[TBL] [Abstract][Full Text] [Related]
5. Application of a binary polymer system in drug release rate modulation. 1. Characterization of release mechanism.
Kim H; Fassihi R
J Pharm Sci; 1997 Mar; 86(3):316-22. PubMed ID: 9050799
[TBL] [Abstract][Full Text] [Related]
6. Formulation and release characteristics of hydroxypropyl methylcellulose matrix tablet containing melatonin.
Lee BJ; Ryu SG; Cui JH
Drug Dev Ind Pharm; 1999 Apr; 25(4):493-501. PubMed ID: 10194604
[TBL] [Abstract][Full Text] [Related]
7. Optimisation of floating matrix tablets and evaluation of their gastric residence time.
Baumgartner S; Kristl J; Vrecer F; Vodopivec P; Zorko B
Int J Pharm; 2000 Feb; 195(1-2):125-35. PubMed ID: 10675690
[TBL] [Abstract][Full Text] [Related]
8. Effect of FITC-dextran molecular weight on its release from floating cetyl alcohol and HPMC tablets.
Xu G; Groves MJ
J Pharm Pharmacol; 2001 Jan; 53(1):49-56. PubMed ID: 11206192
[TBL] [Abstract][Full Text] [Related]
9. Effect of hydroxypropylmethylcellulose (HPMC) on the release profiles and bioavailability of a poorly water-soluble drug from tablets prepared using macrogol and HPMC.
Ishikawa T; Watanabe Y; Takayama K; Endo H; Matsumoto M
Int J Pharm; 2000 Jul; 202(1-2):173-8. PubMed ID: 10915941
[TBL] [Abstract][Full Text] [Related]
10. Application of binary polymer system in drug release rate modulation. 2. Influence of formulation variables and hydrodynamic conditions on release kinetics.
Kim H; Fassihi R
J Pharm Sci; 1997 Mar; 86(3):323-8. PubMed ID: 9050800
[TBL] [Abstract][Full Text] [Related]
11. An in vitro investigation into the potential for bimodal drug release from pectin/chitosan/HPMC-coated tablets.
Macleod GS; Fell JT; Collett JH
Int J Pharm; 1999 Oct; 188(1):11-8. PubMed ID: 10528078
[TBL] [Abstract][Full Text] [Related]
12. Influence of admixed citric acid on the release profile of pelanserin hydrochloride from HPMC matrix tablets.
Espinoza R; Hong E; Villafuerte L
Int J Pharm; 2000 May; 201(2):165-73. PubMed ID: 10878323
[TBL] [Abstract][Full Text] [Related]
13. Determination of continuous changes in the gel layer thickness of poly(ethylene oxide) and HPMC tablets undergoing hydration: a texture analysis study.
Yang L; Johnson B; Fassihi R
Pharm Res; 1998 Dec; 15(12):1902-6. PubMed ID: 9892476
[No Abstract] [Full Text] [Related]
14. High molecular weight polyethylene oxides (PEOs) as an alternative to HPMC in controlled release dosage forms.
Maggi L; Bruni R; Conte U
Int J Pharm; 2000 Feb; 195(1-2):229-38. PubMed ID: 10675700
[TBL] [Abstract][Full Text] [Related]
15. Development of a multifunctional matrix drug delivery system surrounded by an impermeable cylinder.
Krögel I; Bodmeier R
J Control Release; 1999 Aug; 61(1-2):43-50. PubMed ID: 10469901
[TBL] [Abstract][Full Text] [Related]
16. Synchronized release of sulpiride and sodium decanoate from HPMC matrices: a rational approach to enhance sulpiride absorption in the rat intestine.
Baluom M; Friedman M; Assaf P; Haj-Yehia AI; Rubinstein A
Pharm Res; 2000 Sep; 17(9):1071-6. PubMed ID: 11087038
[TBL] [Abstract][Full Text] [Related]
17. Modeling of drug release from erodible tablets.
Katzhendler I; Hoffman A; Goldberger A; Friedman M
J Pharm Sci; 1997 Jan; 86(1):110-5. PubMed ID: 9002469
[TBL] [Abstract][Full Text] [Related]
18. Development and evaluation of a multiple-unit oral sustained release dosage form for S(+)-ibuprofen: preparation and release kinetics.
Cox PJ; Khan KA; Munday DL; Sujja-areevath J
Int J Pharm; 1999 Dec; 193(1):73-84. PubMed ID: 10581424
[TBL] [Abstract][Full Text] [Related]
19. In vitro/in vivo studies on a buccal bioadhesive tablet formulation of carbamazepine.
Ikinci G; Capan Y; Senel S; Alaaddinoğlu E; Dalkara T; Hincal AA
Pharmazie; 2000 Oct; 55(10):762-5. PubMed ID: 11082839
[TBL] [Abstract][Full Text] [Related]
20. HPMC-matrices for controlled drug delivery: a new model combining diffusion, swelling, and dissolution mechanisms and predicting the release kinetics.
Siepmann J; Kranz H; Bodmeier R; Peppas NA
Pharm Res; 1999 Nov; 16(11):1748-56. PubMed ID: 10571282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
